Most of the cases reported were of breast cancer. Men mainly had throat cancer, and the reason was the use of chemicals, lengthy wars and the use of different weaponry in the country, said Sharafat Zaman, a Taliban spokesperson.
According to a study led by the Mayo Clinic Comprehensive Cancer Center, women who have cancer in one breast may be more likely to develop cancer in the opposite breast if they carry specific genetic changes that predispose them to develop breast cancer.
According to a study led by the Mayo Clinic Comprehensive Cancer Center, women who have cancer in one breast may be more likely to develop cancer in the opposite breast if they carry specific genetic changes that predispose them to develop breast cancer.
According to Sun Pharma, Palbociclib is approved by the US Food and Drugs Administration (FDA), European Medicines Agency (EMA) and Central Drugs Standard Control Organisation (CDSCO) in combination with hormonal therapies for patients with hormone receptor-positive, human epidermal growth f
Researchers have uncovered a series of molecular interactions that may be crucial in preventing the spread of cancer cells. There is currently no effective therapeutic strategy to stop metastasis, which is the main cause of death from solid malignant tumours.
A new method can illuminate the identities and activities of cells throughout an organ or a tumour at unprecedented resolution, according to a study co-led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and the New York Genome Center.
Mumbai (Maharashtra) [India], January 3 (ANI/PRNewswire): Datar Cancer Genetics announced today that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation' for its 'TriNetra™-Glio', a blood test to help in the diagnosis of brain tumors. This is the thir
It is not the first time the 66-year-old will battle cancer having overcome the deadly disease earlier. The veteran tennis player was diagnosed with cancer for the first time in 2010 when she was 53.
Approximately 70 per cent of breast cancer cases are hormonally driven, and treatment involves oral oestrogen blockers. However, the medications can induce joint pain, which is why many women stop taking them, placing them at an increased risk of relapse.
Researchers have developed a brand-new method for locating and eliminating cancer cells by using synthetic DNA. The procedure was successful in lab tests against cells generated from human cervical cancer, human breast cancer, and mouse malignant melanoma.
Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias, lymphomas and breast cancer. Anthracyclines -- such as doxorubicin, frequently used against breast cancer -- kill cancer cells by damaging their DNA.